Use of C-type natriuretic peptide variants to treat skeletal dysplasia

The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), and novel pharmaceutical compositions and formulations comprising CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias, such as long bone growth or growth ve...

Full description

Saved in:
Bibliographic Details
Main Authors Bullens, Sherry, Wendt, Daniel J, Bunting, Stuart, Yap, Clarence, Chou, Tianwei, Okhamafe, Augustus O, Price, Christopher P
Format Patent
LanguageEnglish
Published 03.09.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), and novel pharmaceutical compositions and formulations comprising CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, and other disorders having a skeletal dysplasia and/or CNP-associated symptom or component.
Bibliography:Application Number: US202318157573